Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal Research

Financing Buprenorphine Treatment in Primary Care: A Microsimulation Model

Jonathan E. Fried, Sanjay Basu, Russell S. Phillips and Bruce E. Landon
The Annals of Family Medicine November 2020, 18 (6) 535-544; DOI: https://doi.org/10.1370/afm.2587
Jonathan E. Fried
1Center for Primary Care, Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjay Basu
1Center for Primary Care, Harvard Medical School, Boston, Massachusetts
2Research and Population Health, Collective Health, San Francisco, California
3School of Public Health, Imperial College London, London, United Kingdom
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sanjay_basu@hms.harvard.edu
Russell S. Phillips
1Center for Primary Care, Harvard Medical School, Boston, Massachusetts
4Division of General Internal Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce E. Landon
1Center for Primary Care, Harvard Medical School, Boston, Massachusetts
4Division of General Internal Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts
5Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
MD, MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Description of identified buprenorphine care delivery models.

    NCM = nurse care manager; OBOT = office-based opioid treatment.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Differences in long-term (after Year 1) minimum net revenue increase with variations in the no-show rate for induction and maintenance, across practice types and alternative approaches for office-based opioid treatment with buprenorphine.

    FQHC = federally qualified health center; MD = medical doctor; OBOT-B = office-based opioid treatment with buprenorphine; RN = registered nurse; SH = shared; SO=solo.

    Note: Results take into account variation in prevalence of opioid use disorder among different practice types. These terms were defined as follows: FQHC: federally qualified health centers and look-alikes; Urban: non-FQHC in high-poverty urban ZIP Code (≥20% of households below poverty threshold); Rural: non-FQHC in high-poverty rural ZIP Code (≥20% of households below poverty threshold); Other: practice in lower-poverty ZIP Code; MD: OBOT-B with physician-led visits4; RN: OBOT-B with nurse-led visits28; SH: OBOT-B with shared visits28; SO: OBOT-B with solo provider30.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Differences in long-term (after Year 1) minimum net revenue increase with variations in the prevalence of opioid use disorder, across practice types and alternative approaches for office-based opioid treatment with buprenorphine.

    FQHC = federally qualified health center; MD = medical doctor; OBOT-B = office-based opioid treatment with buprenorphine; RN = registered nurse; SH = shared; SO=solo.

    Note: These terms were defined as follows: FQHC: federally qualified health centers and look-alikes; Urban: non-FQHC in high-poverty urban ZIP Code (≥20% of households below poverty threshold); Rural: non-FQHC in high-poverty rural ZIP Code (≥20% of households below poverty threshold); Other: practice in lower-poverty ZIP Code; MD: OBOT-B with physician-led visits4; RN: OBOT-B with nurse-led visits28; SH: OBOT-B with shared visits29; SO: OBOT-B with solo provider30.

Tables

  • Figures
  • Additional Files
    • View popup
    Table 1.

    Input Data and Descriptive Details for Alternative Approaches for Office-Based Opioid Treatment With Buprenorphine

    OBOT-B With Physician-Led Visits4OBOT-B With Nurse-Led Visits34OBOT-B With Shared Visits35OBOT-B With Solo Provider36
    Visit frequency (per patient per year), based on interviews, No.
    Initial medical evaluation (99204/G0466a)1111
    Follow-up medical evaluation, Level 3 (99213/G0467)1511816
    Follow-up medical evaluation, Level 4 (99214/G0467)1401
    Follow-up nursing visit (99211)01310
    Behavioral health intake assessment (90791/G0469; combined with initial medical evaluation)1110
    Group psychotherapy (90853), 12 patients per group1919180
    Urine drug screen (80305/G0477)19192018
    Staff time, based on interviews
    Physician hours (SD), per patient per year4.8 (1.2)2.0 (0.5)2.9 (0.7)5.2 (1.3)
    Nurse care manager hours (SD), per patient per year1.1 (0.3)4.0 (1.0)4.0 (1.0)
    Behaviorist hours (SD), per patient per year2.4 (0.7)2.5 (0.8)3.0 (0.8)
    Year 1 additional physician hours (SD)16.0 (5.0)16.0 (5.0)16.0 (5.0)32.0 (10.0)
    Year 1 nurse and behaviorist additional setup hours (SD)40.0 (10.0)40.0 (10.0)40.0 (10.0)
    Hours (SD) worked per full-time equivalent employee per year372,087.0 (96.0)2,087.0 (96.0)2,087.0 (96.0)2,087.0 (96.0)
    • OBOT-B = office-based opioid treatment with buprenorphine.

    • Note: For insurance rates, we sampled from the probability distribution of Medicare payer prevalence. If a simulated individual was not selected to have Medicare, we sampled from the Medicaid prevalence. If the simulated individual was not selected to have Medicaid, we sampled from the private insurance prevalence. If the individual was not selected to have private insurance, they were assigned as self-pay/uninsured. Payment rates were log-transformed before sampling to adjust for skew and were determined from the Medicare Physician Fee Schedule Look-up Tool, publicly available state Medicaid fee schedules, and the Collective Health database of commercial payment rates.42-44 Appropriate billing codes for OBOT-B were determined in consultation with interviewed primary care practice representatives and informed by guidance from the Centers for Medicare & Medicaid Services, Substance Abuse and Mental Health Services Administration, and National Association of Community Health Centers.36-38

    • ↵a Current Procedural Terminology (CPT) visit codes.

    • View popup
    Table 2.

    Input Data and Descriptive Details for Practice-Level Data by Clinic Type

    FQHC or FQHC Look-AlikeNon-FQHC in High-Poverty Urban ZIP Code (≥20% of Households Below Poverty Threshold)Non-FQHC in High-Poverty Rural ZIP Code (≥20% of Households Below Poverty Threshold)Practice in Lower-Poverty ZIP Code
    Demand for therapy
    Prevalence of opioid use disorder, % (SD)381.3 (0.2)1.3 (0.2)1.6 (0.4)0.8 (0.3)
    Screening tool sensitivity, % (SD)39100.0 (0)100.0 (0)100.0 (0)100.0 (0)
    Screening tool specificity, % (SD)3973.5 (1.8)73.5 (1.8)73.5 (1.8)73.5 (1.8)
    Proportion of patients accepting therapy when offered, based on interviews, % (SD)80.0 (2.5)80.0 (2.5)80.0 (2.5)80.0 (2.5)
    No-show rate, % (SD)2622.0 (5.0)20.0 (5.0)25.0 (5.0)20.0 (5.0)
    Practice characteristic
    Panel size, all patients per full-time physician, No. (SD)402,040 (551)1,480 (316)1,760 (357)1,620 (337)
    Payer prevalence, Medicare, % (SD)4011 (3)27 (7)20 (5)22 (6)
    Payer prevalence, Medicaid, % (SD)4057 (14)20 (5)18 (5)13 (3)
    Payer prevalence, private, % (SD)4010 (3)48 (12)48 (12)60 (15)
    Payer prevalence, uninsured/self-pay, % (SD)4022 (6)5 (1)14 (4)5 (1)
    Salary and overhead costs26,40,41
    Nurse care manager salary per year, $ (SD)65,683 (8,624)73,101 (7,418)57,059 (8,624)81,724 (8,623)
    Behaviorist salary per year, $ (SD)50,713 (9,321)58,266 (7,553)41,392 (9,321)67,957 (9,691)
    Overhead rate, % (SD)47 (14)47 (14)47 (14)47 (14)
    • FQHC = federally qualified health center; OBOT-B = office-based opioid treatment with buprenorphine.

    • Note: For insurance rates, we sampled from the probability distribution of Medicare payer prevalence. If a simulated individual was not selected to have Medicare, we sampled from the Medicaid prevalence. If the simulated individual was not selected to have Medicaid, we sampled from the private insurance prevalence. If the individual was not selected to have private insurance, they were assigned as self-pay/uninsured. Payment rates were log-transformed before sampling to adjust for skew and were determined from the Medicare Physician Fee Schedule Look-up Tool, publicly available state Medicaid fee schedules, and the Collective Health database of commercial payment rates.42-44 Appropriate billing codes for OBOT-B were determined in consultation with interviewed primary care practice representatives and informed by guidance from the Centers for Medicare & Medicaid Services, Substance Abuse and Mental Health Services Administration, and National Association of Community Health Centers.36-38

    • View popup
    Table 3.

    Input Data and Descriptive Details for Payment by Insurance Type42-44

    Visit TypeMedicare $ (SD)Medicaid $ (SD)Private $ (SD)Uninsured/Self-Pay $ (SD)
    Initial medical evaluation (99204/G0466a)158.80 (22.80)106.60 (31.40)222.70 (2.40)106.60 (31.40)
    Follow-up medical evaluation, Level 3 (99213/G0467)68.00 (13.80)45.50 (12.70)111.10 (0.90)45.50 (12.70)
    Follow-up medical evaluation, Level 4 (99214/G0467)101.70 (18.20)68.60 (21.20)156.70 (1.20)68.60 (21.20)
    Follow-up nursing visit (99211)17.40 (7.60)10.80 (6.20)46.80 (1.80)10.80 (6.20)
    Behavioral health intake assessment (90791/G0469)142.60 (11.70)73.10 (6.00)126.40 (2.70)73.10 (6.00)
    Group psychotherapy (90853), 12 patients per group28.00 (2.20)14.40 (1.10)151.90 (21.30)14.40 (1.10)
    Urine drug screen (80305/G0477)13.50 (2.80)11.90 (2.50)55.00 (27.30)11.90 (2.50)
    • OBOT-B = office-based opioid treatment with buprenorphine.

    • Note: For insurance rates, we sampled from the probability distribution of Medicare payer prevalence. If a simulated individual was not selected to have Medicare, we sampled from the Medicaid prevalence. If the simulated individual was not selected to have Medicaid, we sampled from the private insurance prevalence. If the individual was not selected to have private insurance, they were assigned as self-pay/uninsured. Payment rates were log-transformed before sampling to adjust for skew and were determined from the Medicare Physician Fee Schedule Look-up Tool, publicly available state Medicaid fee schedules, and the Collective Health database of commercial payment rates.42-44 Appropriate billing codes for OBOT-B were determined in consultation with interviewed primary care practice representatives and informed by guidance from the Centers for Medicare & Medicaid Services, Substance Abuse and Mental Health Services Administration, and National Association of Community Health Centers.36-38

    • ↵a Current Procedural Terminology (CPT) visit codes.

    • View popup
    Table 4.

    Primary and Secondary Outcomes in the First Year of Buprenorphine Treatment Implementation (Year 1) and in Each Subsequent Year (After Year 1 for Each of 10 Years) Across 4 Approaches for Office-Based Opioid Treatment With Buprenorphine, and Among the Different Simulated Practice Types

    Gross Revenue $ (95% CI)Opportunity Costs $ (95% CI)New Personnel and Overhead Costs $ (95% CI)Net Revenue $ (95% CI)
    Year 1
    FQHC
       Physician-led41,769 (17,408-73,092)6,395 (2,517-12,393)6,514 (3,508-10,647)28,859 (9,247-54,294)
       Nurse-led35,857 (15,013-63,183)3,240 (1,438-5,964)9,746 (4,929-16,344)22,870 (6,258-45,087)
       Shared41,942 (17,390-73,618)4,081 (1,716-7,573)9,193 (4,700-15,475)28,668 (9,026-55,032)
       Solo29,656 (12,298-52,300)7,880 (3,374-14,569)021,776 (7,964-40,045)
    Urban
       Physician-led59,641 (27,589-104,484)7,508 (3,471-13,481)6,364 (3,632-9,832)45,769 (17,812-85,568)
       Nurse-led54,576 (24,983-96,817)3,996 (2,014-6,793)8,974 (5,062-14,234)41,606 (15,280-79,472)
       Shared59,046 (27,545-103,358)4,931 (2,429-8,497)8,521 (4,810-13,509)45,593 (17,826-85,198)
       Solo35,112 (16,659-61,275)9,552 (4,779-16,355)025,560 (10,299-47,435)
    Rural
       Physician-led85,035 (34,078-157,980)10,027 (4,086-19,218)5,642 (2,966-9,378)69,366 (24,814-134,442)
       Nurse-led77,939 (30,947-146,822)5,041 (2,317-9,133)8,575 (4,285-14,885)64,323 (22,021-126,578)
       Shared84,142 (34,404-155,899)6,368 (2,838-11,789)8,092 (4,091-14,110)69,682 (24,761-134,089)
       Solo49,895 (20,589-92,754)12,299 (5,549-22,553)037,596 (13,617-73,853)
    Other
       Physician-led45,677 (10,184-97,483)5,976 (2,115-12,076)6,302 (3,338-10,049)33,399 (2,990-79,070)
       Nurse-led42,193 (9,386-91,756)3,399 (1,506-6,194)8,296 (4,168-14,212)30,499 (2,065-75,037)
       Shared45,116 (10,211-96,573)4,078 (1,696-7,662)7,929 (3,949-13,301)33,108 (2,651-79,258)
       Solo26,085 (5,935-55,506)7,944 (3,303-14,887)018,141 (1,702-42,051)
    Year 2+
    FQHC
       Physician-led41,769 (17,408-73,092)5,519 (1,779-11,327)3,234 (1,159-6,404)33,016 (13,567-58,589)
       Nurse-led35,857 (15,013-63,183)2,357 (749-4,925)6,455 (2,345-12,448)27,044 (10,820-49,205)
       Shared41,942 (17,390-73,618)3,204 (1,024-6,509)5,903 (2,108-11,579)32,835 (13,388-59,298)
       Solo29,656 (12,298-52,300)6,119 (1,979-12,547)023,538 (9,683-41,899)
    Urban
       Physician-led59,641 (27,589-104,484)6,153 (2,333-12,012)2,660 (1,145-5,016)50,828 (22,860-90,418)
       Nurse-led54,576 (24,983-96,817)2,631 (977-5,113)5,257 (2,237-9,696)46,688 (20,264-84,319)
       Shared59,046 (27,545-103,358)3,575 (1,358-6,884)4,806 (2,053-8,917)50,664 (23,090-90,283)
       Solo35,112 (16,659-61,275)6,829 (2,576-13,015)028,283 (12,938-50,689)
    Rural
       Physician-led85,035 (34,078-157,980)8,716 (2,901-17,783)3,671 (1,337-7,339)72,649 (28,513-137,390)
       Nurse-led77,939 (30,947-146,822)3,721 (1,228-7,608)5,786 (2,116-11,413)68,432 (26,186-130,898)
       Shared84,142 (34,404-155,899)5,058 (1,703-10,353)5,305 (1,945-10,692)73,779 (29,224-138,600)
       Solo49,895 (20,589-92,754)9,664 (3,263-19,592)040,231 (16,037-76,726)
    Other
       Physician-led45,677 (10,184-97,483)4,512 (1,107-7,623)2,080 (427-4,650)39,085 (8,650-85,210)
       Nurse-led42,193 (9,386-91,756)1,923 (371-4,339)4,058 (860-9,042)36,212 (7,785-80,774)
       Shared45,116 (10,211-96,573)2,615 (503-5,939)3,695 (813-8,171)38,806 (8,649-84,639)
       Solo26,085 (5,935-55,506)5,000 (983-11,455)021,086 (4,697-45,406)
    • FQHC = federally qualified health center.

    • Note: The 4 approaches were (1) buprenorphine therapy via prescriber-led visits, which involved prescribers leading routine visits for medication management with a nurse care manager providing program coordination, intake visits, telephone outreach, and induction management, (2) buprenorphine therapy via nurse-led visits, which involved a nurse care manager leading patient visits and care management and prescribers meeting the patient every 3 months after induction for medication management, (3) buprenorphine therapy via shared medical appointments, which involved the prescribers leading a weekly group visit (including medication titration) in concert with a behaviorist and nurse care manager, and (4) buprenorphine therapy via a solo prescriber, which involved the physician prescribing buprenorphine without major structural support from auxiliary staff. The 4 practice types were (1) FQHCs and FQHC look-alikes, (2) non-FQHC practices in high-poverty urban areas by Census definition (>20% of households within the ZIP Code having an income below the federal poverty threshold after adjustment for household size), (3) non-FQHC practices in high-poverty rural areas by Census definition (>20% of households within the ZIP Code having an income below the federal poverty threshold after adjustment for household size), and (4) practices outside of high-poverty areas.

Additional Files

  • Figures
  • Tables
  • Supplemental Appendix & Table

    Supplemental Appendix & Table

    Files in this Data Supplement:

    • Supplemental data: Appendix & Table - PDF file
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 18 (6)
The Annals of Family Medicine: 18 (6)
Vol. 18, Issue 6
1 Nov 2020
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
  • The Issue in Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Financing Buprenorphine Treatment in Primary Care: A Microsimulation Model
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Financing Buprenorphine Treatment in Primary Care: A Microsimulation Model
Jonathan E. Fried, Sanjay Basu, Russell S. Phillips, Bruce E. Landon
The Annals of Family Medicine Nov 2020, 18 (6) 535-544; DOI: 10.1370/afm.2587

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Financing Buprenorphine Treatment in Primary Care: A Microsimulation Model
Jonathan E. Fried, Sanjay Basu, Russell S. Phillips, Bruce E. Landon
The Annals of Family Medicine Nov 2020, 18 (6) 535-544; DOI: 10.1370/afm.2587
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Figures and Tables
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Agile Implementation of a Digital Cognitive Assessment for Dementia in Primary Care
  • Authorship Inequity in Global Health Research Conducted in Low- and Middle-Income Countries and Published in High-Income Country Family Medicine Journals
  • Feasibility and Acceptability of Implementing a Digital Cognitive Assessment for Alzheimer Disease and Related Dementias in Primary Care
Show more Original Research

Similar Articles

Subjects

  • Methods:
    • Mixed methods
  • Other research types:
    • PBRN research
    • Professional practice
  • Other topics:
    • Organizational / practice change

Keywords

  • primary care
  • opioid use disorder
  • health care financing
  • buprenorphine

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine